Status:
COMPLETED
Fatigue a Long COVID-19 Symptom Substudy of FSC19-KN Trial
Lead Sponsor:
Hegau-Bodensee-Klinikum Singen
Conditions:
SARS-CoV2 Infection
Eligibility:
All Genders
18+ years
Brief Summary
Prospective, controlled follow-up observation of SARS-CoV-2 positive patients with regard to the aspect of fatigue (cognitive / motor) and psychological disorders in the areas of anxiety, depression a...
Detailed Description
After informed consent is given, questionnaires will be obtained 6 months and 12 months after infection. For analyzing cognitive and motor fatigue, classified in mildly, moderately or severely fatigue...
Eligibility Criteria
Inclusion
- Patient must meet ALL of the following criteria.
- Participation in the FSC19-KN study
- Consent to participate in the survey
Exclusion
- 1\. Failure to give consent to the survey
Key Trial Info
Start Date :
May 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
353 Patients enrolled
Trial Details
Trial ID
NCT04883190
Start Date
May 15 2021
End Date
February 1 2024
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hegau Bodensee Klinikum Singen
Singen, Baden-Wurttemberg, Germany, 78224